J&J’s ketamine-derived nasal spray approved by FDA to treat depression
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.
pulmonaryfibrosisnews1d
Why fact-checking is important in the rare disease world
The internet is full of false claims. Columnist Sam Kirton shares why fact-checking is important, particularly for the rare disease world.
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment
The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major ...